Innovations

Found results: 1005

Note to the businessman

Catch up? Overtake???

It is not entirely clear how the development of domestic sequencers looks from a technical and economic point of view...

13.11.2017
Note to the businessman

Longevity Industry

The review is addressed to investment firms and large companies interested in medical methods to combat aging.

24.10.2017
Innovative Russia

The best venture investor

The winners of the National Award "Venture Investor-2017" were announced in Moscow within the framework of the International Forum "Open Innovations".

20.10.2017
Note to the businessman

Live money

This year, new records are expected to be set in terms of investments in the fields of life sciences and digital medicine.

13.10.2017
Biotechnologies - into life

Complete collection of bacteriophages

The project is being implemented within the framework of the State Strategy for Preventing the Spread of Antimicrobial Resistance.

12.10.2017
Innovative Russia

Surgical robot and new Russian drugs

The First International Medical Investment Forum was held at the Congress Center of the First Moscow State Medical University.

10.10.2017
Biotechnologies - into life

Millions to fight tuberculosis

A unique Russian drug for the treatment of antibiotic-resistant tuberculosis attracted investments in the amount of 44 million rubles.

09.10.2017
Innovative Russia

Secrets of the Soviet bioprom

Academician Viktor Tutelyan – about whether Russian biotechnology has chances not to completely lag behind the Western countries and China.

26.09.2017
Innovative Russia

Work in biomedicine

The Biomedtech Job Fair allowed companies working in the field of biomedical technologies and job seekers to get to know each other.

26.09.2017
Note to the businessman

Playing by the new rules

PharmaTimes portal discussed the future of artificial intelligence technologies in pharmaceuticals with AI expert Jackie Hunter.

22.09.2017
Biotechnologies - into life

Precursors for cancer diagnosis

The product "Pharm-Synthesis.Lab" is cheaper and better than foreign analogues and is already being delivered to one of the hospitals in St. Petersburg.

22.09.2017
Innovative Russia

How to create a biobank

St. Petersburg University hosted the first biobanking school in Russia, which was attended by doctors and biologists from all over the country.

21.09.2017
Innovative Russia

Problems and plans of "Biocade"

Dmitry Morozov – about innovations, the fight against aging, a new program to support the pharmaceutical industry and the company's plans in the Middle East.

21.09.2017
Biotechnologies - into life

Moderna Therapeutics: Medicinal futurism

Interest in the achievements of Modern Therapeutics in the innovative therapeutic field based on matrix RNA (mRNA) is warmed up as never before.

18.09.2017
Biotechnologies - into life

Clinical case

In the future, gene therapy can save people from many diseases. In practice, the first important step has been taken: for the first time this method has been approved for use in oncology.

01.09.2017
Note to the businessman

How to beat old age

Ilya Popov, member of the industry working groups under the Ministry of Finance of the Russian Federation, the Chamber of Commerce and Industry of the Russian Federation and Business Russia - on the prospects for the development of the biomedical technologies market.

01.09.2017
Innovative Russia

"Biocad" expands the database

The unique data warehouse contains more than 600 billion molecules, which were obtained from 1,758 donors. The project has been implemented by the biotech company BIOCAD since 2014.

25.08.2017
Note to the businessman

The prospects of epigenetics are questionable

Roche did not want to license its leading candidate drug for the treatment of acute myeloid leukemia and solid tumors from the Spanish Orizn Ginomix.

24.07.2017
Biotechnologies - into life

Investing in genome editing

The technology of gene therapy of patients with lymphomas and HIV is at an early stage of preclinical studies and already at this stage was able to attract the attention of the investor.

19.07.2017